Sanofi

Sanofi (SNY) is ramping up efforts to boost shareholder returns, announcing plans to repurchase up to €1 billion (about $1.20 billion) of its own shares between...

(RTTNews) - Sanofi (SNY, SAN.PA), a French pharmaceutical and healthcare company, on Monday said it has signed a mandate to execute a 1 billion euros share buyb...

Sanofi SA (NASDAQ:SNY) has been found to have violated the U.K.'s pharmaceutical marketing code after a senior executive made misleading claims in an October 20...

On Monday, Sanofi SA (NASDAQ:SNY) shared topline data from results from the LEAP2MONO phase 3 study of once daily oral venglustat versus intravenous enzyme repl...

Sanofi SA ((SNY)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and po...

Deutsche Bank lowered the firm’s price target on Sanofi (SNY) to EUR 100 from EUR 105 and keeps a Buy rating on the shares. Published first on TheFly – the ult...

This vaccine-focused biotech reported a significant insider sale as it advances its hepatitis B franchise and global partnerships. David Novack, President & CO...

The European Medicines Agency’s Committee for Medicinal Products for Human Use, CHMP, has adopted a positive opinion recommending the conditional marketing auth...

TrumpRx — the government’s drug pricing initiative, which is at the center of the tariff deals the administration has reached with drugmakers since September —...

Sanofi ( (SNY) ) just unveiled an announcement. On January 29, 2026, Sanofi reported that in 2025 it delivered strong top- and bottom-line growth, with full-ye...